Oncology Corporate Profile
Nanobiotix is an oncology focused nanomedicine company developing an innovative nanoparticle technology. Nanobiotix is developing new tools for cancer which utilize a physical mode of action at the cellular level of the cancer cell. The NanoXray technology comprises three products having the potential to cause a paradigm shift in cancer therapy. Specifically, NanoXray products may overcome the current limitations of standard of care in local therapy.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|NBTXR3||radiotherapeutic||Head & Neck cancer||I|
|NBTXR3||radiotherapeutic||Hepatocellular carcinoma (HCC)||I|
|NBTXR3||radiotherapeutic||Various cancer types||I|
View additional information on product candidates here »